• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 IgG 和补体 3 水平可区分 2 型糖尿病患者的非糖尿病性肾脏疾病与糖尿病肾病。

Serum levels of immunoglobulin G and complement 3 differentiate non-diabetic renal disease from diabetic nephropathy in patients with type 2 diabetes mellitus.

机构信息

Division of Nephrology, West China Hospital of Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, China.

出版信息

Acta Diabetol. 2019 Aug;56(8):873-881. doi: 10.1007/s00592-019-01339-0. Epub 2019 Apr 19.

DOI:10.1007/s00592-019-01339-0
PMID:31004313
Abstract

AIMS

Heavy proteinuria caused by non-diabetic renal disease (NDRD) is common in type 2 diabetes mellitus (T2DM). The aim of this study was to investigate specific predictors for NDRD in addition to traditional indicators in T2DM.

METHODS

A total of 341 patients with T2DM who underwent renal biopsy were retrospectively included. Eligible patients were divided into a nephrotic-range group (n = 194) and a non-nephrotic-range group (n = 147) based on proteinuria level. Risk factors for NDRD were evaluated using logistic regression, and the diagnostic implications of these variables were assessed by subgroup.

RESULTS

Multivariate logistic regression indicated that serum IgG level (OR, 0.762; 95% CI, 0.628-0.924; p = 0.006) was an independent predictor of NDRD in the nephrotic-range group. However, in the non-nephrotic-range group, increased C3 level was an independent risk factor for NDRD (OR, 1.313; 95% CI, 1.028-1.678; p = 0.029). In the nephrotic-range group, the optimal cutoff value of IgG for predicting NDRD was 734.0 mg/dl, with 67.8% sensitivity and 74.8% specificity, and IgG ≤ 734.0 mg/dl was the best predictor of NDRD. In the non-nephrotic-range group, the optimal cutoff value of C3 for predicting NDRD was 122.0 mg/dl with low sensitivity (30.9%) but high specificity (97.8%).

CONCLUSIONS

At different levels of proteinuria, reduced IgG and increased C3 levels were independent indicators of NDRD in T2DM. Insights into these factors will help to advance the clinical management of NDRD.

摘要

目的

非糖尿病性肾脏疾病(NDRD)引起的大量蛋白尿在 2 型糖尿病(T2DM)中很常见。本研究旨在探讨除 T2DM 中的传统指标外,NDRD 的特定预测因素。

方法

共纳入 341 例接受肾活检的 T2DM 患者,进行回顾性分析。根据蛋白尿水平,将合格患者分为肾病范围组(n=194)和非肾病范围组(n=147)。使用逻辑回归评估 NDRD 的危险因素,并通过亚组评估这些变量的诊断意义。

结果

多变量逻辑回归表明,血清 IgG 水平(OR,0.762;95%CI,0.628-0.924;p=0.006)是肾病范围组中 NDRD 的独立预测因素。然而,在非肾病范围组中,C3 水平升高是 NDRD 的独立危险因素(OR,1.313;95%CI,1.028-1.678;p=0.029)。在肾病范围组中,预测 NDRD 的 IgG 最佳截断值为 734.0mg/dl,灵敏度为 67.8%,特异性为 74.8%,IgG≤734.0mg/dl 是预测 NDRD 的最佳指标。在非肾病范围组中,预测 NDRD 的 C3 最佳截断值为 122.0mg/dl,灵敏度低(30.9%)但特异性高(97.8%)。

结论

在不同蛋白尿水平下,降低的 IgG 和升高的 C3 水平是 T2DM 中 NDRD 的独立指标。深入了解这些因素将有助于推进 NDRD 的临床管理。

相似文献

1
Serum levels of immunoglobulin G and complement 3 differentiate non-diabetic renal disease from diabetic nephropathy in patients with type 2 diabetes mellitus.血清 IgG 和补体 3 水平可区分 2 型糖尿病患者的非糖尿病性肾脏疾病与糖尿病肾病。
Acta Diabetol. 2019 Aug;56(8):873-881. doi: 10.1007/s00592-019-01339-0. Epub 2019 Apr 19.
2
Immunoglobulin G levels can predict non-diabetic renal disease in patients with type 2 diabetes mellitus.免疫球蛋白 G 水平可预测 2 型糖尿病患者的非糖尿病性肾脏疾病。
J Diabetes. 2012 Mar;4(1):37-40. doi: 10.1111/j.1753-0407.2011.00175.x.
3
Clinicopathological study of nondiabetic renal disease in type 2 diabetic patients: A single center experience from India.2型糖尿病患者非糖尿病性肾脏疾病的临床病理研究:来自印度的单中心经验
Saudi J Kidney Dis Transpl. 2017 Nov-Dec;28(6):1330-1337. doi: 10.4103/1319-2442.220877.
4
Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients.在大量2型糖尿病患者中区分非糖尿病性肾脏疾病与糖尿病肾病的临床预测因素。
Diabetes Res Clin Pract. 2016 Nov;121:112-118. doi: 10.1016/j.diabres.2016.09.005. Epub 2016 Sep 21.
5
Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.2型糖尿病合并肾脏受累患者的肾脏病理意义
J Diabetes Complications. 2017 Jan;31(1):114-121. doi: 10.1016/j.jdiacomp.2016.10.024. Epub 2016 Oct 26.
6
Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria.2型糖尿病伴肾病范围蛋白尿患者糖尿病和非糖尿病肾脏疾病的临床病理特征
Medicine (Baltimore). 2017 Sep;96(36):e8047. doi: 10.1097/MD.0000000000008047.
7
Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients.设计和验证 2 型糖尿病患者糖尿病肾病与非糖尿病肾脏疾病鉴别诊断的评分模型。
J Diabetes. 2020 Mar;12(3):237-246. doi: 10.1111/1753-0407.12994. Epub 2019 Dec 2.
8
Non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus.非胰岛素依赖型糖尿病患者的非糖尿病肾病
Yonsei Med J. 1999 Aug;40(4):321-6. doi: 10.3349/ymj.1999.40.4.321.
9
Non diabetic renal disease in type 2 diabetes mellitus.2型糖尿病中的非糖尿病性肾脏疾病
Nephrology (Carlton). 2006 Dec;11(6):533-7. doi: 10.1111/j.1440-1797.2006.00681.x.
10
Implication of decreased serum complement 3 in patients with diabetic nephropathy.血清补体 3 降低对糖尿病肾病患者的影响。
Acta Diabetol. 2018 Jan;55(1):31-39. doi: 10.1007/s00592-017-1060-4. Epub 2017 Oct 17.

引用本文的文献

1
Serum total protein-to-albumin ratio and adverse clinical outcomes in patients with diabetes and chronic kidney disease: a comparative study of US and Chinese cohorts.糖尿病合并慢性肾脏病患者的血清总蛋白与白蛋白比值及不良临床结局:美国和中国队列的比较研究
Int Urol Nephrol. 2025 Aug 6. doi: 10.1007/s11255-025-04673-1.
2
A Machine Learning Model for Predicting Diabetic Nephropathy Based on TG/Cys-C Ratio and Five Clinical Indicators.基于甘油三酯/胱抑素C比值和五项临床指标的糖尿病肾病预测机器学习模型
Diabetes Metab Syndr Obes. 2025 Mar 31;18:955-967. doi: 10.2147/DMSO.S502649. eCollection 2025.
3
Complement Cascade Proteins Correlate with Fibrosis and Inflammation in Early-Stage Type 1 Diabetic Kidney Disease in the Ins2Akita Mouse Model.
补体级联蛋白与早期 1 型糖尿病肾病模型 Ins2Akita 小鼠的纤维化和炎症相关。
Int J Mol Sci. 2024 Jan 23;25(3):1387. doi: 10.3390/ijms25031387.
4
The Complement Pathway: New Insights into Immunometabolic Signaling in Diabetic Kidney Disease.补体途径:糖尿病肾病中免疫代谢信号的新见解。
Antioxid Redox Signal. 2022 Oct;37(10-12):781-801. doi: 10.1089/ars.2021.0125. Epub 2022 Feb 7.
5
Identification of C3 as a therapeutic target for diabetic nephropathy by bioinformatics analysis.通过生物信息学分析鉴定 C3 为糖尿病肾病的治疗靶点。
Sci Rep. 2020 Aug 10;10(1):13468. doi: 10.1038/s41598-020-70540-x.
6
Insights into the Role of Renal Biopsy in Patients with T2DM: A Literature Review of Global Renal Biopsy Results.2型糖尿病患者肾活检作用的见解:全球肾活检结果的文献综述
Diabetes Ther. 2020 Sep;11(9):1983-1999. doi: 10.1007/s13300-020-00888-w. Epub 2020 Aug 5.